Ignite Creation Date:
2025-12-25 @ 1:47 AM
Ignite Modification Date:
2026-05-07 @ 2:38 PM
Study NCT ID:
NCT06363994
Status:
RECRUITING
Last Update Posted:
2024-12-27
First Post:
2024-04-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL
Sponsor:
InnoCare Pharma Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ICP-CL-00128
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None